Navigation Links
American Society for Microbiology honors Anne M. Vidaver
Date:7/14/2008

Washington, DCMay 28, 2008The 2008 American Society for Microbiology (ASM) Founders Distinguished Service Award is being presented to Anne M. Vidaver, Professor of Plant Pathology, University of Nebraska, Lincoln. This award recognizes an ASM member for outstanding contributions and commitment to the ASM as a volunteer at the national level.

For 30 years, Dr. Vidaver has been an outstanding leader and a persistent and effective advocate for research and policy issues related to microbiology, especially agricultural and environmental microbiology. Dr. Vidaver, who is a Fellow of the American Academy of Microbiology, is a two-time ASM Foundation Lecturer and a past Advisory Board member of the Center for the History of Microbiology. Her ASM service also includes the Committee on the Status of Women in Microbiology, the Procter & Gamble Award Selection Committee, and the Public and Scientific Affairs Board Committee on Agricultural, Food and Industrial Microbiology, which she chaired from 1994-2003. In addition, she has organized and moderated several ASM symposia and participated in several AAM colloquia. Dr. Vidaver has accomplished all of this in addition to an outstanding national service record. From 2000-2002, she served as Chief Scientist for the USDA, where she chaired the Interagency Working Group for the Microbe Project, which enabled a collaborative effort on genomic sequencing of microbes that is now funded at over $20 million each year.

Dr. Vidaver received her received her B.A. in Biology from Russell Sage College, Troy, New York, and her M.S. and Ph.D. in Bacteriology from Indiana University.

The ASM Founders Distinguished Service Award will be presented during the 108th General Meeting of the American Society for Microbiology (ASM), June 1 June 5, 2008 in Boston, Massachusetts. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the
'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. American Society for Microbiology honors Arturo Casadevall
2. American Society for Microbiology honors Bala Swaminathan
3. American Society for Microbiology honors Bernard Roizman
4. American Society for Microbiology honors D. Scott Merrell
5. American Society for Microbiology honors David J. Lipman
6. American Society for Microbiology honors Ekaterina Helwein
7. American Society for Microbiology honors Eric Skaar
8. American Society for Microbiology honors Walter Stamm
9. American Society for Microbiology honors Douglas Weibel
10. American Society for Microbiology honors Adrian M. Zelazny
11. American Chemical Societys Weekly PressPac -- July 9, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... one of your muscles can twitch, before the though...iny floodgate of sortscalled an ion channelmust op...let in the chemical signals that spur the cell to ... Standards and Technology (NIST) has allowed scien...embrane for the first time, potentially offering i...
(Date:12/2/2009)..., NY, December 2, 2009 Commonly prescribed beta 2...hma in pregnant women as well as pre-term labor ma...ers, psychiatric pathology, cognitive problems and...ing to a new study published in the December 2009 ...ecology . , Beta 2 adrenergic agonist drugs as a...
(Date:12/2/2009)...Hall, a PhD student at the University of Southampt...he National Oceanography Centre, Southampton (NOCS...crab, all from the deep sea. , Hall discovered t...he National Museum of Natural History in Washingto...id: "King crabs include some of the largest crusta...
Breaking Biology News(10 mins):Nervy research: Researchers take initial look at ion channels in a model system 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2King crab family bigger than ever 2Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 1Authentidate Holding Corp to Report Fiscal 2010 First Quarter Results on Monday November 16 2009 61295 2Soligenix Reports Third Quarter 2009 Financial Results 14827 1Soligenix Reports Third Quarter 2009 Financial Results 14827 2Soligenix Reports Third Quarter 2009 Financial Results 14827 3Soligenix Reports Third Quarter 2009 Financial Results 14827 4Soligenix Reports Third Quarter 2009 Financial Results 14827 5Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 1Millar Instruments and Harvard Apparatus Improve Ability to Provide Customers With Total Physiology Solutions Through Joint Distribution Agreement 6245 2
... biodegradable polymers called polyketals and thei...mmatory illnesses as acute lung injury, acute live...ring drugs, proteins and snips of ribonucleic acid...al microparticles we developed are simply a vehicl... area as quickly as possible," said Niren Murthy, ...
...l Human Genome Research Institute (NHGRI), part of...arded more than $20 million in grants to develop i...efficient enough to sequence a person,s DNA as a r.... , "The ability to comprehensively sequence any...d to usher in an age of personalized medicine wher...
...to unravel gonadotrophs , Although the basic de...nown, it has been harder to associate specific cha... limited cell population. In an article on p. 546 ...uction , Feng et al. take the approach of comparin...nes that were immortalized at different stages of ...
Other Biology News:Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 2NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 3NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 4NHGRI seeks DNA sequencing technologies fit for routine laboratory and medical use 5September 2008 Biology of Reproduction highlights 2
(Date:12/2/2009)... Peregrine Pharmaceutical... of patient enrollment in a dose confirmation and ...elapsed glioblastoma multiforme (GBM), the deadlie...oclonal antibody linked to a radioisotope being de...ara specifically targets cells at the center of br...
(Date:12/2/2009)...ands, December 2 Pepscan Holding N...using on protein mimicking,technology for the gene... it,has appointed Wim E.M. Mol, Ph.D. as new Chief...ponsible for all of Pepscans corporate functions a...of the company. He brings to,Pepscan more than 20 ...
(Date:12/2/2009)...RNewswire/ -- S*BIO Pte Ltd today announced data p...518, at The American Society of Hematology 51st An...Data will be presented on the clinical results fro...iling its safety, tolerability and pharmacokinetic...nging from 100 to 600 mg. These doses were adminis...
(Date:12/2/2009)...swire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ...rmaceutical company focused on endocrine therapy a...d Drug Administration (FDA) has granted Fast Track...hibitor compound, perifosine (KRX-0401), for the t...Keryx Biopharmaceuticals, Inc. ("Keryx") ( KERX), ...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...How Organizations Can Make the Transition to SPL R...uring Virtify, Inc. , , CAMBRIDGE, Mass., April ...t leader in Enterprise Content Compliance solution...ilgrimsoftware.com ), a provider of Enterprise Co...lutions, will host a complimentary Webinar on bes...
...Call/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ...sults for the first quarter ended March 31, 2009. ...irst quarter in what has been a difficult business... Hunter, President and CEO of Angiotech. "Sales in...ess areas continued to show very promising growth,...
... Inc. has announced today that it has entered into...al, Inc. (Nasdaq: DATA ) to offer the most compr...utical, biotechnology and medical device companies...Inclinix to leverage DATATRAK,s eClinical(TM) plat...ent Contract Research Organization (CRO). This all...
Other Biology Technology:Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 2Event Alert: 'SPL R4 Compliance and its Impact on Regulatory Submission Processes' 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 2Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 3Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 4Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 5Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 6Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 7Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 8Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 9Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 10Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 11Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 12Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 13Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 14Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 15Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 16Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 17Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 18Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 19Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 20Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009 21DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 2DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 3DATATRAK International, Inc. Forms Strategic Partnership with Inclinix, Inc. 4
Goat Anti-Bag-1 (K-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Treponema Pallidum IgM ELISA Kit, Single from Bio-Quant Inc.
Treponema Pallidum Total ELISA Kit, Single from Bio-Quant Inc.
Gel Loading Dye (Bromophenol Blue/Glycerol) from Mo Bio Laboratories, Inc.
Biology Products: